First gene therapy successful against human aging

Discussion in 'Biology & Genetics' started by Plazma Inferno!, Apr 22, 2016.

  1. Plazma Inferno! Ding Ding Ding Ding Administrator

    Messages:
    4,610
    Elizabeth Parrish, CEO of Bioviva USA Inc. has become the first human being to be successfully rejuvenated by gene therapy, after her own company’s experimental therapies reversed 20 years of normal telomere shortening.
    Telomere score is calculated according to telomere length of white blood cells (T-lymphocytes). This result is based on the average T-lymphocyte telomere length compared to the American population at the same age range. The higher the telomere score, the "younger" the cells.
    In September 2015, then 44 year-old CEO of BioViva USA Inc. Elizabeth Parrish received two of her own company’s experimental gene therapies: one to protect against loss of muscle mass with age, another to battle stem cell depletion responsible for diverse age-related diseases and infirmities.
    Telomere data taken from her white blood cells immediately before therapies were administered, revealed that Parrish’s telomeres were unusually short for her age, leaving her vulnerable to age-associated diseases earlier in life.
    In March 2016, the same tests were taken again by SpectraCell revealed that her telomeres had lengthened by approximately 20 years, from 6.71kb to 7.33kb.

    http://bioviva-science.com/2016/04/21/first-gene-therapy-successful-against-human-aging/

    This is actually a big deal.
     
    joepistole likes this.

Share This Page